81
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer

, , , , , , , , , & show all
Pages 1449-1460 | Published online: 19 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Rui-jun Ju, Lan Cheng, Yao Xiao, Xin Wang, Cui-qing Li, Xiao-ming Peng & Xue-tao Li. (2018) PTD modified paclitaxel anti-resistant liposomes for treatment of drug-resistant non-small cell lung cancer. Journal of Liposome Research 28:3, pages 236-248.
Read now
Xiao-li Song, Rui-jun Ju, Yao Xiao, Xin Wang, Shuang Liu, Min Fu, Jing-jing Liu, Li-yan Gu, Xue-tao Li & Lan Cheng. (2017) Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer. International Journal of Nanomedicine 12, pages 7433-7451.
Read now
Asadullah Madni, Amna Batool, Sobia Noreen, Irsah Maqbool, Faizza Rehman, Prince Muhammad Kashif, Nayab Tahir & Ahmad Raza. (2017) Novel nanoparticulate systems for lung cancer therapy: an updated review. Journal of Drug Targeting 25:6, pages 499-512.
Read now
Xi Yang, Zhaojun Li, Qinjie Wu, Shouchun Chen, Cheng Yi & Changyang Gong. (2017) TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors. Drug Delivery 24:1, pages 1526-1536.
Read now

Articles from other publishers (2)

Ehsan Razeghian, Wanich Suksatan, Heshu Sulaiman Rahman, Dmitry O. Bokov, Walid Kamal Abdelbasset, Ali Hassanzadeh, Faroogh Marofi, Mahboubeh Yazdanifar & Mostafa Jarahian. (2021) Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges. Frontiers in Immunology 12.
Crossref
Nadezhda Knauer, Ekaterina Pashkina & Evgeny Apartsin. (2019) Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins. Pharmaceutics 11:2, pages 91.
Crossref